Mergers & Acquisitions - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

1 to 25 of 637 results

EUSA Pharma launches as an independent business with portfolio and name acquired from Jazz

23-03-2015

EUSA Pharma (EUSA), a newly-established profitable specialty pharmaceutical business headquartered in…

Essex BidcoEUSA PharmaJazz PharmaceuticalsMergers & AcquisitionsPharmaceuticalUK

Malin raises up to 330 million euros; to list on Irish Stock Exchange

20-03-2015

Malin Corporation, a newly-incorporated Irish-based global life sciences company, says it has raised…

FinancialIrelandMalin CorpMergers & AcquisitionsPharmaceutical

Pharma and biotech M&A deals reached record $212 billion in 2014

Pharma and biotech M&A deals reached record $212 billion in 2014

19-03-2015

Despite a slight wobble in the spring, the pharma and biotech sector came back stronger than ever in…

BiotechnologyFinancialGlobalMergers & AcquisitionsPharmaceutical

Actavis’ acquisition of Allergan cleared by Europe

Actavis’ acquisition of Allergan cleared by Europe

17-03-2015

Ireland-headquartered generics major Actavis has received clearance from the European Commission for…

ActavisAllerganEuropeMergers & AcquisitionsPharmaceutical

UPDATE: Valeant ups bid for Salix by 9.5%, which is accepted

UPDATE: Valeant ups bid for Salix by 9.5%, which is accepted

16-03-2015

As had been widely expected, acquisitive Canadian drugmaker Valeant Pharmaceutical International has…

Endo InternationalGastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceutical International

Kura Oncology gains rights to Janssen’s tipifarnib

14-03-2015

USA-based clinical-stage drug developer Kura Oncology has entered into an agreement with Janssen Pharmaceutica,…

FinancialJanssen PharmaceuticaJohnson & JohnsonKura OncologyLicensingMergers & AcquisitionsOncologyPharmaceuticaltipifarnib

Endo attempting to outbid Valeant for Salix Pharma

Endo attempting to outbid Valeant for Salix Pharma

12-03-2015

Salix Pharmaceuticals late yesterday confirmed that it has received an unsolicited proposal from Ireland-headquartered…

Endo InternationalMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceutical International

Pernix to acquire Zohydro ER franchise from Zogenix

11-03-2015

US CNS focused drugmaker Zogenix has entered into a definitive agreement to sell its Zohydro ER (hydrocodone…

Mergers & AcquisitionsNeurologicalPernix TherapeuticsPharmaceuticalZogenixZohydro

Concordia spends $1.2 billion on Covis Pharma assets

10-03-2015

Canadian pharma and medical devices company Concordia Healthcare Corp has entered into a definitive asset…

Concordia HealthcareCovis PharmaGenericsMergers & AcquisitionsPharmaceutical

AbbVie chief executive defends Pharmacyclics deal in the face of analyst criticism

AbbVie chief executive defends Pharmacyclics deal in the face of analyst criticism

09-03-2015

As analysts question the price AbbVie paid for Pharmacyclics, AbbVie’s chief executive Richard Gonzalez…

AbbVieImbruvicaMergers & AcquisitionsPharmaceuticalPharmacyclicsUSA

Italy’s Alfa Wassermann and Sigma-Tau to merge

06-03-2015

Alfa Wassermann and Sigma-Tau, two important Italian pharmaceutical groups, with strong international…

Alfa WassermannItalyMergers & AcquisitionsPharmaceuticalSigma-Tau

Mallinckrodt to expand hospital growth platform with Ikaria acquisition

05-03-2015

US drugmaker Mallinckrodt has entered into an agreement to acquire Ikaria, a privately-held critical…

IkariaInomaxMallinckrodtMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Sun Pharma to buy GSK’s opiates business in Australia

Sun Pharma to buy GSK’s opiates business in Australia

03-03-2015

UK pharma major GlaxoSmithKline and India’s largest drugmaker by sales, Sun Pharmaceutical Industries,…

AustraliaGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalSun Pharmaceutical Industries

GSK and Novartis complete major three-part transaction

02-03-2015

UK pharma major GlaxoSmithKline said this morning that its three-part transaction with Swiss peer Novartis…

GlaxoSmithKlineMergers & AcquisitionsNovartisOncologyPharmaceuticalVaccines

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

28-02-2015

Anglo-Swedish pharma major AstraZeneca is changing the structure of its small-molecule early-stage anti-infectives…

Antibiotics and Infectious diseasesAstraZenecaMergers & AcquisitionsPharmaceuticalResearchUK

2015 outlook for US and EU pharma; report

2015 outlook for US and EU pharma; report

27-02-2015

According to this Global Pharma US & EU Outlook 2015 report, strategy diversification stays divested…

EuropeManagementMarkets & MarketingMergers & AcquisitionsPatentsPharmaceuticalUSA

Takeda acquires 13 products from Turkish company Neutec

Takeda acquires 13 products from Turkish company Neutec

25-02-2015

Takeda GmbH, the wholly-owned subsidiary of Japanese drugmaker Takeda has signed an agreement to obtain…

Markets & MarketingMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalTurkey

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

24-02-2015

The US Federal Trade Commission has put conditions on the proposed acquisition by Novartis of GlaxoSmithKline’s…

Array BioPharmaGSKLegalMergers & AcquisitionsNovartisOncologyPharmaceuticalRegulationResearchUSA

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

23-02-2015

US pharma major Bristol-Myers Squibb has signed a definitive agreement to acquire all of the outstanding…

Bristol-Myers SquibbF001287FlexusLicensingMergers & AcquisitionsOncologyPharmaceuticalRigel Pharmaceuticals

UPDATE: Valeant confirms $10 billion offer for Salix

UPDATE: Valeant confirms $10 billion offer for Salix

23-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International late Sunday confirmed it has reached…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Valeant in final stages of making $10 billion offer for Salix; reports

Valeant in final stages of making $10 billion offer for Salix; reports

22-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International could announce an around $10 billion…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Fresenius Kabi sells German oncology compounding business

Fresenius Kabi sells German oncology compounding business

17-02-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has sold its German subsidiary CFL…

CFLFreseniusFresenius KabiGermanyMergers & AcquisitionsNewCo PharmaOncologyPharmaceutical

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

11-02-2015

UK pharma major GlaxoSmithKline this morning said that it has acquired Switzerland-based GlycoVaxyn,…

GlaxoSmithKlineGlycoVaxynMergers & AcquisitionsPharmaceuticalVaccines

1 to 25 of 637 results

Back to top